Some visit links earn us a commission.

Lowest compounded tirzepatide drug price in New York 2026: $69 a month, plus yearly membership

Compounded tirzepatide, a pharmacy-made version that is not Zepbound or Mounjaro, ships to New York from four of our partner programs. The lowest of the programs we track is $69 a month at Collective, plus a yearly membership, read on November 11, 2026.

Medicaid for weight loss
Not covered
Partner programs that ship here
Eden, Collective, SnagRx and CoreAge Rx
Adults with obesity
28.5% (CDC, 2025)

Compounded tirzepatide prices in New York

ProgramMonthly priceCheckedProgram's site
Eden logoEden$129 a monthNovember 11, 2026Check price →
Collective logoCollective$69 a month, plus yearly membershipNovember 11, 2026Check price →
SnagRx logoSnagRx$149 a month, or $119 a month paid 12 months up frontNovember 11, 2026
CoreAge Rx logoCoreAge Rx$129 a monthNovember 11, 2026

Eden, Collective, SnagRx and CoreAge Rx pay GLP Chart when you buy through our links.

What a year of compounded tirzepatide costs in New York

  • Eden ships to New York at $1,548 for 12 months.
  • Collective ships to New York at $1,027 for 12 months with its membership.
  • SnagRx ships to New York at $1,788 for 12 months, or $1,428 if New York buyers pay 12 months up front.
  • CoreAge Rx ships to New York at $1,548 for 12 months.

For compounded semaglutide, New York buyers pay from $59 a month at Collective, plus a yearly membership, against $69 for compounded tirzepatide in New York.

Does New York Medicaid cover Zepbound?

New York Medicaid does not cover Zepbound for weight loss. It does cover Zepbound for obstructive sleep apnea, with prior authorization. New York Medicaid plans include Healthfirst, Fidelis Care (Centene), EmblemHealth and MetroPlus Health Plan. No New York Medicaid plan pays for compounded tirzepatide, so it is a cash purchase. New York Medicaid GLP-1 rules.

Obesity in New York

28.5% of adults in New York had obesity in 2025, by the CDC's state survey, against 33.5% for the US as a whole. That puts New York 5.0 points below the national rate, about 3 in 10 New York adults.

More for New York

Compounded tirzepatide is made by a licensed pharmacy to a prescription and is not FDA-approved. A prescriber decides whether it suits you.